Search Results for: mira

Posted on by and

Funding Opportunities: Addressing Structural Racism and Discrimination

UPDATE: The funding opportunity, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional) (RFA-MD-21-004), is now available. A pre-application technical assistance workshop will be held on May 26, 1-2:30 p.m. ET. See NOT-MD-21-018 for details. We want to make you aware of two funding …

Continue reading “Funding Opportunities: Addressing Structural Racism and Discrimination”

Posted on by , , and

NIGMS Training Application and Funding Trends: Individual NRSA Postdoc and Pathway to Independence Awards

Our Division of Training, Workforce Development, and Diversity (TWD) supports programs at multiple career stages to foster the development of a strong and diverse biomedical research workforce. This post is the first in a series focused on data from NIGMS training programs and is similar to the ones we have done for our research project …

Continue reading “NIGMS Training Application and Funding Trends: Individual NRSA Postdoc and Pathway to Independence Awards”

Posted on by

Funding Opportunity: R21/R33 to Test Existing or New Biospecimens from Sepsis Patients

We’ve issued a new funding opportunity announcement (FOA): Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 – Clinical Trial Not Allowed) (PAR-21-077). This FOA aims to promote the optimal use, testing, and sharing of patient-derived materials. It stems from recommendations of the NAGMSC working group on sepsis and input from …

Continue reading “Funding Opportunity: R21/R33 to Test Existing or New Biospecimens from Sepsis Patients”

Posted on by , , and

What Can We Do to Combat Anti-Black Racism in the Biomedical Research Enterprise?

The recent deaths of George Floyd, Ahmaud Arbery, and Breonna Taylor, in addition to the disproportionate burden of COVID-19 on African Americans, are wrenching reminders of the many harms that societal racism, inequality, and injustice inflict on the Black community. These injustices are rooted in centuries of oppression—including slavery and Jim Crow, redlining, school segregation, …

Continue reading “What Can We Do to Combat Anti-Black Racism in the Biomedical Research Enterprise?”

Posted on by and

Application and Funding Trends in Fiscal Year 2019

UPDATE: Figure 2 of this post was updated slightly in March 2021 to reflect NIGMS-supported Early Stage Investigator counts more accurately. On December 20, 2019, the Further Consolidated Appropriations Act, 2020 , was signed into law. The appropriation provides NIGMS with a budget of $2,937,218,000 in Fiscal Year (FY) 2020, a 2.2% increase over the FY …

Continue reading “Application and Funding Trends in Fiscal Year 2019”

Posted on by

How do I know if my work fits in the mission of NIGMS?

Ninety percent of the applications to our Maximizing Investigators’ Research Award for Early Stage Investigators (known as the ESI MIRA program) that were submitted in October are about to undergo peer review. The remaining 10% were administratively withdrawn, mostly because the research proposed fell outside the NIGMS mission. This is comparable to the proportion that …

Continue reading “How do I know if my work fits in the mission of NIGMS?”

Posted on by

Does your application fit the scientific mission of NIGMS?

Prospective applicants frequently ask us whether their application ideas fit within our mission. NIGMS supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. We also support research in some specific clinical areas that affect multiple organ systems, including anesthesia, sepsis, wound healing, …

Continue reading “Does your application fit the scientific mission of NIGMS?”

Posted on by and

Application and Funding Trends in Fiscal Year 2018

UPDATE: Figure 2 of this post was updated slightly in March 2021 to reflect NIGMS-supported Early Stage Investigator counts more accurately. On September 28, 2018, the Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019  was signed into law. The law includes an NIGMS budget …

Continue reading “Application and Funding Trends in Fiscal Year 2018”

Posted on by

Administrative Supplements to Add Research on Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias

NIGMS, along with other NIH Institutes and Centers, has partnered with the National Institute on Aging to grow the community of scientists actively engaged in research focused on Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD). Details of this year’s AD/ADRD supplement program are provided in NIA’s Notice NOT-AG-18-008. If your research, research training, or research …

Continue reading “Administrative Supplements to Add Research on Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias”

Posted on by and

Application and Funding Trends in Fiscal Year 2017

NIGMS is committed to ensuring that taxpayers get the best possible returns on their investments in fundamental biomedical research. As part of this commitment to stewardship [PDF 7.89MB], we regularly monitor trends in our funding portfolio. We recognize the value of a diversified investment portfolio and approach our research investments in a similar fashion. Sustaining …

Continue reading “Application and Funding Trends in Fiscal Year 2017”